| Issue |
Title |
File |
| Vol 95, No 1 (2023) |
Possibilities of dispensary observation in reducing mortality from coronary heart disease |
(Rus)
|
|
Boytsov S.A., Provatorov S.I.
|
| Vol 94, No 12 (2022) |
Anemia of chronic diseases: current state of the problem and perspectives |
(Rus)
|
|
Mironova O.I., Panferov A.S.
|
| Vol 94, No 11 (2022) |
Informativeness estimation for the main clinical and laboratory parameters in patients with severe COVID-19 |
(Rus)
|
|
Stanevich O.V., Bakin E.A., Korshunova A.A., Gudkova A.Y., Afanasev A.A., Shlyk I.V., Lioznov D.A., Polushin Y.S., Kulikov A.N.
|
| Vol 94, No 10 (2022) |
Obesity and diabetes – are they always together? |
(Rus)
|
|
Shestakova M.V., Shestakova E.A., Sklyanik I.A., Stafeev I.S.
|
| Vol 94, No 9 (2022) |
Acute decompensation of heart failure: state of the problem |
(Rus)
|
|
Zhirov I.V., Nasonova S.N., Tereshchenko S.N.
|
| Vol 94, No 8 (2022) |
Prospects for personalized Helicobacter pylori eradication therapy. Pro et contra |
(Rus)
|
|
Simanenkov V.I., Alekseenko S.A.
|
| Vol 94, No 7 (2022) |
Chronic thromboembolic pulmonary hypertension: from pathogenesis to the choice of treatment tactics |
(Rus)
|
|
Valieva Z.S., Martynyuk T.V.
|
| Vol 94, No 6 (2022) |
Lupus nephritis in the XXI century |
(Rus)
|
|
Bobkova I.N., Moiseev S.V., Lysenko L.V., Kamyshova E.S.
|
| Vol 94, No 5 (2022) |
Janus kinase inhibitors in immunoinflammatory rheumatic diseases |
(Rus)
|
|
Nasonov E.L.
|
| Vol 94, No 4 (2022) |
Molecular cardiology: from decoding the genetic nature and mechanisms of the diseases development to the introduction into the clinic |
(Rus)
|
|
Zateyshchikov D.A., Favorova O.O., Chumakova O.S.
|
| Vol 94, No 3 (2022) |
Dyspnea: neurobiological and clinical aspects |
(Rus)
|
|
Chuchalin A.G.
|
| Vol 94, No 2 (2022) |
Food intolerances and the small intestine |
(Rus)
|
|
Parfenov A.I.
|
| Vol 94, No 1 (2022) |
Chronic heart failure: evolution of etiology, prevalence and mortality over the past 20 years |
(Rus)
|
|
Boytsov S.A.
|
| Vol 93, No 12 (2021) |
Low adherence to treatment is a weak link in the problems of ulcerative colitis |
(Rus)
|
|
Parfenov A.I., Knyazev O.V., Babayan A.F., Kagramanova A.V.
|
| Vol 93, No 11 (2021) |
Peculiarities of blood coagulation disorders in patients with COVID-19 |
(Rus)
|
|
Evtugina N.G., Sannikova S.S., Peshkova A.D., Safiullina S.I., Andrianova I.A., Tarasova G.R., Khabirova A.I., Rumyantsev A.G., Ataullakhanov F.I., Litvinov R.I.
|
| Vol 93, No 10 (2021) |
Modern problems of hyper- and hypoparathyroidism |
(Rus)
|
|
Mokrysheva N.G., Eremkina A.K., Kovaleva E.V., Krupinova J.A., Vikulova O.K.
|
| Vol 93, No 9 (2021) |
Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future |
(Rus)
|
|
Martynyuk T.V., Chazova I.E.
|
| Vol 93, No 8 (2021) |
Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management |
(Rus)
|
|
Bakulin I.G., Skalinskaya M.I., Maev I.V., Skazyvaeva E.V., Zhuravleva M.S., Gaikovaya L.B., Bakulina N.V., Ermakov A.I., Alekseenko E.S., Ivanova K.N., Solovev M.V.
|
| Vol 93, No 7 (2021) |
Development of program therapy for patients with acute myeloid leukemia under the age of 60 years, based on the principles of differentiated effects |
(Rus)
|
|
Parovichnikova E.N., Lukianova I.A., Troitskaya V.V., Drokov M.Y., Kuzmina L.A., Sokolov A.N., Kokhno A.V., Fidarova Z.T., Galtseva I.V., Davydova Y.O., Kashlakova A.I., Gribanova E.O., Zvonkov E.E., Sysoeva E.P., Dvirnyk V.N., Obukhova T.N., Sudarikov A.B., Sidorova Y.V., Kulikov S.M., Chabaeva Y.A., Savchenko V.G.
|
| Vol 93, No 6 (2021) |
Kidney injury associated with antitumor therapy: focus on the adverse events of modern immuno-oncological drugs |
(Rus)
|
|
Kamyshova E.S., Bobkova I.N., Sekacheva M.I.
|
| Vol 93, No 5 (2021) |
2019 Coronavirus disease (COVID-19): contribution of rheumatology |
(Rus)
|
|
Nasonov E.L.
|
| Vol 93, No 4 (2021) |
Nuclear medicine and molecular imaging in clinical practice: yesterday, today and tomorrow |
(Rus)
|
|
Sergienko V.B., Ansheles A.A.
|
| Vol 93, No 3 (2021) |
COVID-19 and human security |
(Rus)
|
|
Chuchalin A.G.
|
| Vol 93, No 2 (2021) |
Enteropathy with impaired membrane digestion and the prospects for cytoprotective therapy |
(Rus)
|
|
Parfenov A.I., Akhmadullina O.V., Belostotsky N.I., Sabelnikova E.A., Novikov A.A., Bykova S.V., Dbar S.R.
|
| Vol 93, No 1 (2021) |
Modern content and improvement of high cardiovascular risk strategy in reducing mortality from cardiovascular diseases |
(Rus)
|
|
Boytsov S.A., Drapkina O.M.
|
| Vol 92, No 11 (2020) |
Hepatitis C awareness among therapists and general practitioners. Survey results |
(Rus)
|
|
Sineglazova A.V., Sineglazova A.V.
|
| Vol 92, No 10 (2020) |
Iodine deficiency disorders as a non-infectious epidemic: a look at the problem at the tome of COVID-19 pandemic |
(Rus)
|
|
Mel’nichenko G.A., Troshina E.A., Gerasimov G.A.
|
| Vol 92, No 9 (2020) |
COVID-19 and cardiovascular diseases |
(Rus)
|
|
Chazova I.E., Mironova O.I.
|
| Vol 92, No 8 (2020) |
Novel coronavirus infection COVID-19: extrapulmonary manifestations |
(Rus)
|
|
Maev I.V., Shpektor A.V., Vasilyeva E.Y., Manchurov V.N., Andreev D.N.
|
| Vol 92, No 7 (2020) |
Immunosupressive therapy of aplastic anemia patients: successes and failures (single center experiment 2007–2016) |
(Rus)
|
|
Mikhaylova E.A., Fidarova Z.T., Abramova A.V., Luchkin A.V., Troitskaya V.V., Dvirnyk V.N., Galtseva I.V., Kliasova G.A., Kovrigina A.M., Kulikov S.M., Chabaeva Y.А., Parovichnikova E.N., Savchenko V.G., Obukhova T.N.
|
| Vol 92, No 5 (2020) |
Anniversary of the honored scientist professor Sergey Nikolaevich Tereshchenko |
|
|
Therapeutic archive B.
|
| Vol 92, No 3 (2020) |
UNESCO: bioethical initiatives in 2019 |
(Rus)
|
|
Chuchalin A.G.
|
| Vol 92, No 3 (2020) |
Assessment of the respiratory muscles strength at patients with chronic obstructive pulmonary disease with various forms of comorbidity |
(Rus)
|
|
Kurpatov I.G., Geltser B.I., Kinyaikin M.F.
|
| Vol 92, No 3 (2020) |
Systemic inflammation in patients with chronic obstructive pulmonary disease and obesity |
(Rus)
|
|
Ovsyannikov E.S., Avdeev S.N., Budnevsky A.V.
|
| Vol 92, No 3 (2020) |
Comparative analysis of the strength of the respiratory muscles in community-acquired pneumonia with different severity of endogenous intoxication |
(Rus)
|
|
Geltser B.I., Dej A.A., Titorenko I.N., Kotelnikov V.N.
|
| Vol 92, No 3 (2020) |
The risk of bronchial asthma exacerbations among smokers with asthma-chronic obstructive pulmonary disease overlap after inpatient treatment |
(Rus)
|
|
Gnoevykh V.V., Smirnova A.Y., Shorokhova Y.A., Gening T.P., Abakumova T.V.
|
| Vol 92, No 3 (2020) |
Clinical and diagnostical value of 24-hour arterial stiffness monitoring in patients with bronchial asthma |
(Rus)
|
|
Karoli N.A., Zarmanbetova O.T., Rebrov A.P.
|
| Vol 92, No 3 (2020) |
Evaluation of the relationship between the parameters of peripheral skeletal and respiratory muscles in patients with chronic obstructive pulmonary disease |
(Rus)
|
|
Suleymanova A.K., Baranova I.A.
|
| Vol 92, No 3 (2020) |
Fatal severe community-acquired pneumonia: risk factors, clinical characteristics and medical errors of hospital patients |
(Rus)
|
|
Postnikova L.B., Klimkin P.F., Boldina M.V., Gudim A.L., Kubysheva N.I.
|
| Vol 92, No 3 (2020) |
Evaluation of the effectiveness of ARVI treatment regimen including etiotropic (enisamium iodide) and symptomatic treatment |
(Rus)
|
|
Lioznov D.A., Karnaukhova E.J., Zubkova T.G., Shakhlanskaya E.V.
|
| Vol 92, No 3 (2020) |
Changes in gut microbiota with bronchial asthma |
(Rus)
|
|
Zolnikova O.Y., Potskhverashvili N.D., Kudryavtseva A.V., Krasnov G.S., Guvatova Z.G., Truhmanov A.S., Kokina N.I., Ivashkin V.T.
|
| Vol 92, No 3 (2020) |
The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169) |
(Rus)
|
|
Mariandyshev A.O., Khokhlov A.L., Smerdin S.V., Shcherbakova V.S., Igumnova O.V., Ozerova I.V., Bolgarina A.A., Nikitina N.A.
|
| Vol 92, No 2 (2020) |
Systemic manifestations of inflammatory bowel diseases |
(Rus)
|
|
Parfenov A.I., Kagramanova A.V., Knyazev O.V.
|
| Vol 92, No 2 (2020) |
European registry on Helicobacter pylori management (Hp-EuReg) as a tool to evaluate and improve clinical practice in Moscow |
(Rus)
|
|
Bordin D.S., Voynovan I.N., Embutnieks Y.V., Nyssen O.P., Megraud F., O`Morain C., Perez-Gisbert J.
|
| Vol 92, No 2 (2020) |
Esophageal disorders in patients with irritable bowel syndrome |
(Rus)
|
|
Morozova Y.N., Pogromov A.P., Mnatsakanyan M.G., Tashchyan O.V., Kolosova K.Y.
|
| Vol 92, No 2 (2020) |
Diagnostic accuracy of predictive indexes of liver fibrosis in patients with chronic hepatitis C |
(Rus)
|
|
Maev I.V., Kuznetsova E.I., Andreev D.N., Dicheva D.T.
|
| Vol 92, No 2 (2020) |
Evaluation of the effectiveness of differentiated therapy of non-alcoholic fatty liver disease |
(Rus)
|
|
Vakhrushev Y.M., Suchkova E.V., Lukashevich A.P.
|
| Vol 92, No 2 (2020) |
The long-term prospective study of patients with liver cirrhosis after elimination of the hepatitis C virus |
(Rus)
|
|
Nabatchikova E.A., Abdurakhmanov D.T., Nikulkina E.N., Rozina T.P., Tanaschuk E.L., Nikiforova N.V., Adonyeva V.S., Moiseev S.V.
|
| Vol 92, No 2 (2020) |
Сlinical, immunological and morphological features in different types of autoimmune hepatitis |
(Rus)
|
|
Sandler Y.G., Saliev K.G., Backih S.N., Khomeriki S.G., Khaymenova T.Y., Dorofeev A.S., Sbikina E.S., Vinnitskaya E.V.
|
| Vol 92, No 2 (2020) |
Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease |
(Rus)
|
|
Cherkashchenko N.A., Livzan M.A., Krolevets T.S.
|
| 1 - 50 of 3171 Items |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 > >>
|
